DPP-4 inhibitor
Dipeptidyl peptidase-4 inhibitor
- Incretins (GLP-1, GIP) survive longer
- Glucose-dependent ↑ insulin and ↓ glucagon — low hypoglycemia risk
- Weight-neutral
- Rare pancreatitis and bullous pemphigoid reports
- Weight neutral, low hypoglycemia risk
- Rare pancreatitis and joint pain
Drugs with this mechanism (5)
- Alogliptin — DPP-4 inhibitor for type 2 diabetes; weight-neutral but carries a heart-failure warning.
- Gemigliptin — DPP-4 inhibitor used for type 2 diabetes in some countries; weight-neutral with low hypoglycemia risk when used alone.
- Linagliptin — DPP-4 inhibitor for diabetes; uniquely non-renally cleared, no dose adjustment.
- Saxagliptin — DPP-4 inhibitor for diabetes; uniquely burdened by a heart-failure signal.
- Sitagliptin — The first DPP-4 inhibitor; weight-neutral, well tolerated.
All mechanisms · Open DPP-4 inhibitor in the interactive console ↗